(Q38448936)

3 September 2017

title

Non-motor signs in Parkinson's disease: a review (English)

1 reference

3 September 2017

1 reference

Laura Silveira Moriyama

series ordinal

3

object named as

Laura Silveira-Moriyama

1 reference

3 September 2017

Renato P Munhoz

1

1 reference

3 September 2017

Adriana Moro

series ordinal

2

1 reference

3 September 2017

Helio A Teive

series ordinal

4

1 reference

3 September 2017

publication date

17 April 2015

1 reference

Arquivos de Neuro-Psiquiatria

3 September 2017

published in

1 reference

3 September 2017

page(s)

0

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

A critical evaluation of the Braak staging scheme for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Parkinson's disease: the non-motor issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Quality of life and depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Non-recognition of depression and other non-motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory function in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory disturbances in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory threshold in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory function in Parkinson's disease in ON versus OFF states

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Olfactory heterogeneity in LRRK2 related Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Association of olfactory dysfunction with risk for future Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Predicting Parkinson's disease - why, when, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Restoration of normal motor control in Parkinson's disease during REM sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Psychiatric syndromes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

What is the evidence for a premorbid parkinsonian personality: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Frequency of bowel movements and the future risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Body mass index is reduced early in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Body mass index in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Weight loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Dementia and survival in Parkinson disease: a 12-year population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Long-duration Parkinson's disease: role of lateralization of motor features

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

Longitudinal outcome of Parkinson's disease patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150029

10.1590/0004-282X20150029

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

26017214

1 reference